Aviffa RTI liofilizátum szuszpenzióhoz pulykák és házityúkok részére
Aviffa RTI liofilizátum szuszpenzióhoz pulykák és házityúkok részére
Authorised
- Turkey rhinotracheitis virus, strain VCO3, Live
Product identification
Medicine name:
Aviffa RTI liofilizátum szuszpenzióhoz pulykák és házityúkok részére
Active substance:
- Turkey rhinotracheitis virus, strain VCO3, Live
Target species:
-
Turkey
-
Chicken
Route of administration:
-
In drinking water/milk use
-
Intraocular use
-
Nebulisation use
Product details
Active substance and strength:
-
Turkey rhinotracheitis virus, strain VCO3, Live2.30log10 cell culture infective dose 501.00unit(s)/dose
Pharmaceutical form:
-
Oral lyophilisate
Withdrawal period by route of administration:
-
In drinking water/milk use
- Turkey
-
Meat and offal0day
-
- Chicken
-
Meat and offal0day
-
Meat and offal0day
-
-
Intraocular use
- Turkey
-
Meat and offal0day
-
- Chicken
-
Meat and offal0day
-
Meat and offal0day
-
-
Nebulisation use
- Turkey
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: